RIGL Rigel Pharmaceuticals, Inc. Stock Quote

RIGL [NASD]

Index	-	P/E	-	EPS (ttm)	-0.17	Insider Own	0.31%	Shs Outstand	168.93M	Perf Week	5.51%
Market Cap	725.74M	Forward P/E	-	EPS next Y	-0.20	Insider Trans	0.00%	Shs Float	168.46M	Perf Month	18.27%
Income	-27.70M	PEG	-	EPS next Q	-0.11	Inst Own	84.90%	Short Float	11.49%	Perf Quarter	38.42%
Sales	105.60M	P/S	6.87	EPS this Y	9.00%	Inst Trans	-0.31%	Short Ratio	5.13	Perf Half Y	76.43%
Book/sh	0.30	P/B	14.35	EPS next Y	-17.60%	ROA	-20.10%	Target Price	-	Perf Year	99.31%
Cash/sh	0.43	P/C	9.97	EPS next 5Y	-	ROE	-45.00%	52W Range	1.23 - 5.50	Perf YTD	23.00%
Dividend	-	P/FCF	-	EPS past 5Y	17.40%	ROI	-108.60%	52W High	-27.09%	Beta	1.45
Dividend %	-	Quick Ratio	2.90	Sales past 5Y	48.40%	Gross Margin	99.30%	52W Low	226.01%	ATR	0.35
Employees	163	Current Ratio	2.90	Sales Q/Q	-12.00%	Oper. Margin	-26.00%	RSI (14)	45.42	Volatility	6.56% 7.77%
Optionable	Yes	Debt/Eq	0.39	EPS Q/Q	-22.40%	Profit Margin	-26.20%	Rel Volume	1.34	Prev Close	4.30
Shortable	Yes	LT Debt/Eq	0.39	Earnings	Mar 02 AMC	Payout	-	Avg Volume	3.77M	Price	4.01
Recom	1.70	SMA20	-9.91%	SMA50	1.24%	SMA200	42.03%	Volume	3,124,335	Change	-6.85%

Nov-09-20

Downgrade

JP Morgan

Overweight → Neutral

Nov-15-19

Resumed

Cantor Fitzgerald

Overweight

$7 → $5

Sep-26-19

Resumed

JP Morgan

Overweight

Mar-01-19

Reiterated

Cantor Fitzgerald

Overweight

$9 → $7

Aug-27-18

Initiated

Citigroup

Buy

$8.50

May-02-18

Reiterated

Cantor Fitzgerald

Overweight

$6 → $9

Dec-21-17

Resumed

Piper Jaffray

Overweight

Dec-15-17

Initiated

Cantor Fitzgerald

Overweight

Nov-06-17

Resumed

H.C. Wainwright

Buy

Mar-09-17

Reiterated

H.C. Wainwright

Buy

$6 → $5

Aug-31-16

Reiterated

H.C. Wainwright

Buy

$6 → $7

Aug-30-16

Reiterated

Piper Jaffray

Overweight

$10 → $11

Jul-13-16

Initiated

H.C. Wainwright

Buy

Jun-13-16

Initiated

Piper Jaffray

Overweight

Apr-22-16

Upgrade

JP Morgan

Neutral → Overweight

Apr-08-13

Reiterated

Stifel

Buy

$11 → $7

Nov-29-12

Initiated

UBS

Neutral

Nov-06-12

Reiterated

Oppenheimer

Outperform

$12 → $15

Mar-26-12

Initiated

Canaccord Genuity

Hold

Dec-10-10

Downgrade

MP Advisors

Outperform → Market Perform

Mar-02-21 11:51PM	Need To Know: Analysts Are Much More Bullish On Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Revenues Simply Wall St.
05:55PM	Rigel Pharmaceuticals (RIGL) Reports Q4 Loss, Tops Revenue Estimates Zacks
04:01PM	Rigel Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update PR Newswire
02:30PM	Rigel Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Feb-23-21 07:30AM	Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End 2020 Financial Results and Business Update PR Newswire -11.50%
Feb-21-21 07:21AM	3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring Motley Fool
Feb-18-21 12:40PM	Why Rigel Pharmaceuticals Stock Is Jumping Today Motley Fool +5.08%
10:27AM	Rigel Partners With Eli Lilly On Therapy For Autoimmune Disorders; Stock Pops 15% SmarterAnalyst
08:14AM	The Daily Biotech Pulse: Lily-Rigel Licensing Deal, vTv Starts Early Stage Psoriasis Study, Immunic Data Readout Benzinga
07:17AM	UPDATE 1-Eli Lilly in deal with Rigel to develop autoimmune therapy for up to $960 mln Reuters
06:52AM	Rigel Pharma shares soar 39% premarket on news of deal with Eli Lilly MarketWatch
06:30AM	Lilly and Rigel Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases PR Newswire
04:35AM	Rigel Pharmaceuticals Rises on Drug Venture With Eli Lilly TheStreet.com
Jan-29-21 02:45PM	Rigel Awarded $16.5 Million from U.S. Department of Defense for Phase 3 Clinical Trial of Fostamatinib in COVID-19 Patients PR Newswire
04:17AM	If You Had Bought Rigel Pharmaceuticals (NASDAQ:RIGL) Stock A Year Ago, You Could Pocket A 49% Gain Today Simply Wall St.
Jan-22-21 01:36PM	This former Michigan State University basketball player started selling mortgages in his 20s now he's worth more than $11 billion Yahoo Finance
Jan-11-21 07:30AM	Rigel Pharmaceuticals Provides Business Update PR Newswire
Jan-07-21 07:30AM	Rigel to Present at the 39th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-21-20 08:55AM	Is the Options Market Predicting a Spike in Rigel Pharmaceuticals (RIGL) Stock? Zacks
Dec-19-20 10:40PM	Is RIGL A Good Stock To Buy Now According To Hedge Funds? Insider Monkey
Dec-15-20 02:51AM	What Type Of Shareholders Own The Most Number of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares? Simply Wall St.
Dec-04-20 07:30AM	Rigel Announces Two Posters Highlighting TAVALISSE at the 62nd ASH Annual Meeting & Exposition PR Newswire
Nov-23-20 07:30AM	Rigel and Medison Announce Health Canada Approval of TAVALISSE®, an Oral Medication for the Treatment of Adults with Chronic Immune Thrombocytopenia PR Newswire
Nov-17-20 07:30AM	Rigel Finalizes the Study Design of its Ongoing Phase 3 Clinical Trial of Fostamatinib in Warm Autoimmune Hemolytic Anemia PR Newswire
Nov-10-20 07:30AM	Rigel to Present at the Jefferies Virtual London Healthcare Conference PR Newswire
Nov-09-20 08:07AM	Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Just Released Its Third-Quarter Earnings: Here's What Analysts Think Simply Wall St.
Nov-06-20 03:01PM	Rigel Pharmaceuticals Inc (RIGL) Q3 2020 Earnings Call Transcript Motley Fool
Nov-05-20 06:35PM	Rigel Pharmaceuticals (RIGL) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM	Rigel Reports Third Quarter 2020 Financial Results and Provides Business Update PR Newswire
02:30PM	Rigel Pharmaceuticals, Inc. to Host Earnings Call ACCESSWIRE
Oct-29-20 07:30AM	Rigel Announces Conference Call and Webcast to Report Third Quarter 2020 Financial Results and Business Update PR Newswire
Oct-14-20 01:47PM	Hedge Funds Are Piling Into Rigel Pharmaceuticals, Inc. (RIGL) Insider Monkey
Oct-09-20 07:30AM	Rigel Announces First Patients Enrolled in NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova PR Newswire
Oct-02-20 12:26PM	Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) Path To Profitability Simply Wall St.
Sep-18-20 10:52AM	Rigel Announces Sponsored Mid-Stage Coronavirus Therapy Study Zacks
Sep-17-20 09:46AM	Return On Capital Employed Overview: Rigel Pharmaceuticals Benzinga
07:53AM	Rigel's stock jumps on start of Phase 2 trial for investigational COVID-19 treatment MarketWatch
07:30AM	NIH launches trial of Rigel drug for severe COVID-19 Reuters
07:30AM	Rigel Announces NIH/NHLBI-Sponsored Trial of Fostamatinib in Hospitalized COVID-19 Patients in Collaboration with Inova PR Newswire
Sep-09-20 07:30AM	Rigel to Present at Two Upcoming Investor Conferences PR Newswire
Sep-02-20 07:30AM	Rigel to Participate in Citi's 15th Annual BioPharma Virtual Conference PR Newswire
Aug-27-20 01:09PM	Rigel Pharmaceuticals (NASDAQ:RIGL) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway Simply Wall St.
Aug-21-20 07:30AM	Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) PR Newswire
Aug-05-20 11:48AM	Looking Into Rigel Pharmaceuticals's Return On Capital Employed Benzinga
02:01AM	Rigel Pharmaceuticals Inc (RIGL) Q2 2020 Earnings Call Transcript Motley Fool
Aug-04-20 06:35PM	Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:01PM	Rigel Reports Second Quarter 2020 Financial Results, Provides Business Update, and Overviews COVID-19 Program PR Newswire
03:31PM	3 Strong Buy Penny Stocks That Could Go Boom TipRanks
Jul-28-20 12:33PM	Earnings Preview: Rigel Pharmaceuticals (RIGL) Q2 Earnings Expected to Decline Zacks
07:30AM	Rigel Announces Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Business Update PR Newswire
Jul-27-20 04:04PM	Why Rigel Pharmaceuticals Is Moving Today Benzinga
07:30AM	Rigel Announces Post-hoc Data Analysis of TAVALISSE® in Adult Patients with Immune Thrombocytopenia Published in the British Journal of Haematology PR Newswire
Jul-14-20 05:03PM	Why Rigel Pharmaceuticals Stock Skyrocketed 91% Today Motley Fool +90.97%
01:15PM	Rigel Pharma to Test Potential Drug for Covid-19 Pneumonia TheStreet.com
10:06AM	Morning Market Stats in 5 Minutes Benzinga
07:49AM	Rigel's stock jumps 25% after announcing U.K. trial for possible COVID-19 treatment MarketWatch
07:30AM	Rigel Announces Investigator-Sponsored Trial of Fostamatinib in Patients with COVID-19 Pneumonia PR Newswire
Jul-09-20 08:19AM	Rigel Announces Availability of TAVLESSE® (Fostamatinib Disodium Hexahydrate) in Europe PR Newswire -7.14%
Jun-27-20 09:29PM	Is Rigel Pharmaceuticals, Inc. (RIGL) Going to Burn These Hedge Funds? Insider Monkey
Jun-26-20 08:48AM	Rigel Pharmaceuticals (RIGL) Looks Good: Stock Adds 9.7% in Session Zacks -9.36%
Jun-17-20 07:30AM	Rigel to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference PR Newswire
Jun-12-20 10:03PM	Edited Transcript of RIGL earnings conference call or presentation 5-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-11-20 07:30AM	Rigel to Present Poster Highlighting TAVALISSE at the Virtual Edition of the 25th European Hematology Association (EHA) Annual Congress PR Newswire -7.73%
Jun-03-20 07:30AM	Rigel to Present Four Posters Highlighting IRAK1/4 Inhibitor at the EULAR 2020 E-Congress PR Newswire -5.08%
May-26-20 07:30AM	Rigel to Present at the Jefferies Virtual Healthcare Conference PR Newswire +8.79%
May-08-20 11:03AM	Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Just Reported And Analysts Have Been Cutting Their Estimates Simply Wall St.
May-06-20 12:31PM	Rigel Pharmaceuticals Inc (RIGL) Q1 2020 Earnings Call Transcript Motley Fool -7.65%
May-05-20 06:15PM	Rigel Pharmaceuticals (RIGL) Q1 Earnings Match Estimates Zacks +5.95%
04:01PM	Rigel Reports First Quarter 2020 Financial Results and Provides Business Update PR Newswire
May-01-20 07:30AM	Rigel Announces Change to Virtual Format for 2020 Annual Meeting of Stockholders PR Newswire
Apr-28-20 12:33PM	Rigel Pharmaceuticals (RIGL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Zacks
Apr-27-20 07:30AM	Rigel Announces Conference Call and Webcast to Report First Quarter 2020 Financial Results and Business Update PR Newswire +8.33%
Apr-11-20 10:20AM	Imagine Owning Rigel Pharmaceuticals (NASDAQ:RIGL) While The Price Tanked 57% Simply Wall St.
Mar-24-20 02:19AM	Edited Transcript of RIGL earnings conference call or presentation 27-Feb-20 9:30pm GMT Thomson Reuters StreetEvents +8.39%
Mar-12-20 11:02AM	Is Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) A Volatile Stock? Simply Wall St. -13.26%
Mar-03-20 12:56PM	Analysts: These 3 Strong Buy Penny Stocks Could Gain Over 200% TipRanks
Feb-27-20 06:05PM	Rigel Pharmaceuticals (RIGL) Reports Q4 Loss, Misses Revenue Estimates Zacks -5.99%
Feb-20-20 12:31PM	Earnings Preview: Rigel Pharmaceuticals (RIGL) Q4 Earnings Expected to Decline Zacks
07:30AM	Rigel Announces Conference Call and Webcast to Report Fourth Quarter and Year End Financial Results PR Newswire
Feb-11-20 12:14PM	Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL): Is Breakeven Near? Simply Wall St.
Jan-13-20 05:03PM	Aclaris' MK2 Inhibitor Shows Encouraging Data in Phase I Zacks
07:30AM	Rigel Pharmaceuticals Provides Business Update PR Newswire
Jan-10-20 12:54PM	Is Rigel Pharmaceuticals, Inc.'s (NASDAQ:RIGL) CEO Overpaid Relative To Its Peers? Simply Wall St.
Jan-09-20 08:40AM	Tyme Initiates Dosing in Pivotal Pancreatic Cancer Study Zacks
07:30AM	Rigel to Present at the 38th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-18-19 07:23AM	The Daily Biotech Pulse: Positive Adcom Verdict For Merck, Homology Medicine Slips On Mixed Gene Therapy Efficacy Data Benzinga -6.42%
Dec-17-19 05:00PM	Rigel Announces Chief Commercial Officer Transition PR Newswire
Dec-11-19 02:44PM	Does Rigel Pharmaceuticals (NASDAQ:RIGL) Have A Healthy Balance Sheet? Simply Wall St.
09:50AM	Is Rigel Pharmaceuticals, Inc. (RIGL) A Good Stock To Buy? Insider Monkey
Nov-19-19 08:40AM	Edited Transcript of RIGL earnings conference call or presentation 5-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
Nov-18-19 05:34PM	Rigel Gets Positive CHMP Review for Thrombocytopenia Drug Zacks
Nov-15-19 07:30AM	Rigel Receives Positive CHMP Opinion for Fostamatinib Disodium Hexahydrate for Adult Patients with Chronic Immune Thrombocytopenia (ITP) in Europe PR Newswire
Nov-13-19 07:30AM	Rigel to Present at Jefferies 2019 London Healthcare Conference PR Newswire
Nov-08-19 08:00AM	Pharma Sector Tops in October: Best ETFs & Stocks Zacks +6.13%
Nov-07-19 07:30AM	Rigel Announces Upcoming Data Presentations at the 61st ASH Annual Meeting & Exposition PR Newswire
Nov-06-19 02:32PM	Hedge Funds Have Never Been Less Bullish On Rigel Pharmaceuticals, Inc. (RIGL) Insider Monkey
Nov-05-19 06:05PM	Rigel Pharmaceuticals (RIGL) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM	Rigel Announces Third Quarter 2019 Financial Results PR Newswire
Oct-29-19 10:32AM	Rigel Pharmaceuticals (RIGL) Expected to Beat Earnings Estimates: Can the Stock Move Higher? Zacks -6.06%
07:30AM	Rigel Announces Conference Call and Webcast to Report Third Quarter 2019 Financial Results PR Newswire

Rigel Pharmaceuticals, Inc., a biotechnology company, engages in the discovery and development of small molecule drugs for the treatment of immune and hematologic disorders, cancer, and rare diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trials for warm autoimmune hemolytic anemia; R835, an oral interleukin receptor associated kinase 1/4 inhibitor, which is in phase I clinical trials for autoimmune and inflammatory diseases; and R552, a receptor-interacting protein kinase Inhibitor that is in phase I clinical trials for autoimmune and inflammatory diseases. The company has research and license agreements with Aclaris Therapeutics International Limited for the development and commercialization of janus kinase (JAK) inhibitors for the treatment of alopecia areata and other dermatological conditions; AstraZeneca AB for the development and commercialization of R256, an inhaled JAK inhibitor; BerGenBio AS for the development and commercialization of AXL inhibitors in oncology; and Daiichi Sankyo to develop murine double minute 2 inhibitors for solid and hematological malignancies, as well as license and supply agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize Fostamatinib. It also has a license agreement and strategic collaboration with Eli Lilly and Company to co-develop and commercialize R552 for various indications, including autoimmune and inflammatory diseases. Tavalisse. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience